Accelerate Diagnostics
AXDX
$0.93
Share price
0.00%
Change (1 day)
17.85%
Change (1 year)
Categories
P/S ratio for Accelerate Diagnostics (AXDX)
P/S ratio as of April 2024 (TTM): 1.67
According to Accelerate Diagnostics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.67257. At the end of 2023 the company had a P/S ratio of 4.73.
P/S ratio history for Accelerate Diagnostics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.73 | -13.8% |
| 2022 | 5.49 | -82.22% |
| 2021 | 30.9 | -21.08% |
| 2020 | 39.1 | -60.67% |
| 2019 | 99.4 | -9.59% |
| 2018 | 110 | -68.35% |
| 2017 | 348 | -91.99% |
| 2016 | > 1000 | -42.02% |
| 2015 | > 1000 | 6.58% |
| 2014 | > 1000 | -33.07% |
| 2013 | > 1000 | 386.54% |
| 2012 | > 1000 | 5697.24% |
| 2011 | 37.2 | 747.51% |
| 2010 | 4.39 | -66.98% |
| 2009 | 13.3 | -66.24% |
| 2008 | 39.4 | -80.46% |
| 2007 | 201 | 46.93% |
| 2006 | 137 | 143.95% |
| 2005 | 56.2 | |
| 2004 | N/A | -100% |
| 2003 | 50.8 | 286.67% |
| 2002 | 13.1 | -70.9% |
| 2001 | 45.1 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 5.14 | 207.47% | 🇺🇸 USA |
 Becton Dickinson BDX | 3.47 | 107.21% | 🇺🇸 USA |
 PerkinElmer
PKI | 4.31 | 157.42% | 🇺🇸 USA |
 Bruker BRKR | 4.03 | 140.94% | 🇺🇸 USA |
 NanoString Technologies NSTG | 0.0312 | -98.14% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | 2.96 | 76.98% | 🇺🇸 USA |